Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826) has released an update.
Shanghai Haohai Biological Technology Co., Ltd. has scheduled a board meeting for August 16, 2024, to discuss and approve their interim results for the first half of the year and to consider declaring an interim dividend. This announcement underscores the company’s commitment to transparency and shareholder value. The meeting’s outcomes could be influential for investors and market watchers.
For further insights into HK:6826 stock, check out TipRanks’ Stock Analysis page.
